Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status.
McCoy, J. L.; Rucker, R., and Petros, J. A. (Reprint available from: McCoy JL Immunocomp Lab Inc 320 Corp Ctr Court Stockbridge, GA 30222 USA). Breast Cancer Research & Treatment. 60(3):227-234, 2000 Apr.

Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients
Zellars, R. C.; Hilsenbeck, S. G.; Clark, G. M.; Allred, D. C.; Herman, T. S.; Chamness, G. C., and Elledge, R. M.. Journal of Clinical Oncology. 18(9):1906-1913, 2000 May.

Prognostic significance of young age in breast cance.
Yildirim, E.; Dalgic, T., and Berberoglu, U. r. Journal of Surgical Oncology. 74(4):267-272, 2000 Aug.

American Joint Committee on Cancer Prognostic Factors Consensus Conference Yarbro, J. W.;
Page, D. L.; Fielding, L. P.; Partridge, E. E., and Murphy, G. P.. Cancer. 86(11):2436-2446, 1999 Dec 1.

Expression in breast cancers: associations with p53 and outcome.
Thor, A. D.; Liu, S. Q.; Moore, D. H.; Shi, Q. J., and Edgerton, S. M. p21(WAF1/CIP1) Breast Cancer Research & Treatment. 61(1):33-43, 2000 May.

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): A study of incidence and correlation with outcome in breast cancer.
Thor, A. D.; Liu, S.; Edgerton, S.; Moore, D.; Kasowitz, K. M.; Benz, C. C.; Stern, D. F., and DiGiovanna, M. P.. Journal of Clinical Oncology. 18(18):3230-3239, 2000 Sep 15.

A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study
Tabar, L.; Chen, H. H.; Duffy, S. W.; Yen, M. F.; Chiang, C. F.; Dean, P. B., and Smith, R. A.. Lancet. 355(9202):429-433, 2000 Feb 5.

Prognostic value of histologic grade and proliferative activity in axillary node-positiv breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189.
Simpson, J. F.; Gray, R.; Dressler, L. G.; Cobau, C. D.; Falkson, C. I.; Gilchrist, K. W.; Pandya, K. J.; Page, D. L., and Robert, N. J.. Journal of Clinical Oncology. 18(10):2059-2069, 2000 May.

Diurnal cortisol rhythm as a predictor of breast cancer survival
Sephton, S. E.; Sapolsky, R. M.; Kraemer, H. C., and Spiegel, D. (Reprint available from: Sephton SE Univ Louisville, Sch Med, Dept Psychiat & Behav Sci Louisville, KY 40292 USA). Journal of the National Cancer Institute. 92(12):994-1000, 2000 Jun 21.

Association between immunity and prognostic factors in earl stage breast cancer patients before adjuvant treatment.
Sabbioni, M. E. E.; Siegrist, H. P.; Bacchi, M.; Bernhard, J.; Castiglione, M.; Thurlimann, B.; Bonnefoi, H.; Perey, L.; Herrmann, R.; Goldhirsch, A., and Hurny, C.. Breast Cancer Research & Treatment. 59(3):279-287, 2000 Feb.

Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich, A.; Margaria, E., and Chiusa, L. Journal of Clinical Oncology. 18(16):2948-2956, 2000 Aug.

Microinvasive breast carcinoma - Clinicopathologic analysis of a single institution experience
Padmore, R. F.; Fowble, B.; Hoffman, J.; Rosser, C.; Hanlon, A., and Patchefsky, A. S.. Cancer. 88(6):1403-1409, 2000 Mar 15.

Bone marrow micrometastases in breast cancer patients.
Molino, A.; Pelosi, G.; Micciolo, R.; Turazza, M.; Nortilli, R.; Pavanel, F., and Cetto, G. L. (Reprint available from: Molino A Div Clin Oncol Med Piazzale Stefani 1 I-37126 Verona Italy).. Breast Cancer Research & Treatment. 58(2):123-130, 1999 Nov.

Flow cytometry in primary breast carcinomas. Prognostic impact of proliferative activity.
Michels, J. J.; Duigou, F., and Marnay, J. (Reprint available from: Michels JJ Ctr Francois Baclesse, Dept Pathol F-14076 Caen 5 France).. Breast Cancer Research & Treatment. 62(2):117-126, 2000 Jul.

Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
Linderholm, B.; Grankvist, K.; Wilking, N.; Johansson, M.; Tavelin, B., and Henriksson, R.. Journal of Clinical Oncology. 18(7):1423-1431, 2000 Apr.

Android obesity at diagnosis and breast carcinoma survival - Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body eat distribution and weight gain during life span, and survival from breast carcinoma.
Kumar, N. B.; Cantor, A.; Allen, K., and Cox, C. E. Cancer. 88(12):2751-2757, 2000 Jun 15.

Dietary factors and the survival of women with breast carcinoma
Holmes, M. D.; Stampfer, M. J.; Colditz, G. A.; Rosner, B.; Hunter, D. J., and Willet, W. C.. (vol 86, pg 826, 1999). Cancer. 86(12):2707-2708, 1999 Dec 15.

Association of angiogenesis in lymph node metastases with outcome of breast cancer.
Guidi, A. J.; Berry, D. A.; Broadwater, G.; Perloff, M.; Norton, L.; Barcos, M. P., and Hayes, D. F. (Reprint available from: Hayes DF Georgetown Univ, Lombardi Canc Ctr, Breast Canc Program 3970 Reservoir Rd NW,RB504E Washington, DC 20007 USA).. Journal of the National Cancer Institute. 92(6):486-492, 2000 Mar 15.

Toward a comparison of survival in American and European cancer patients
Gatta, G.; Capocaccia, R.; Coleman, M. P.; Ries, L. A. G.; Hakulinen, T.; Micheli, A.; Sant, M.; Verdecchia, A., and Berrino, F. Cancer. 89(4):893-900, 2000 Aug 15.

Differences in breast cancer prognosis among African-American and Caucasian women.
Dignam, J. J.. Ca: a Cancer Journal for Clinicians. 50(1):50-64, 2000 Jan-Feb.

Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
Braun, S.; Pantel, K.; Muller, P.; Janni, W.; Hepp, F.; Kentenich, C. R. M.; Gastroph, S.; Wischnik, A.; Dimpfl, T.; Kindermann, G.; Riethmuller, G., and Schlimok, G. New England Journal of Medicine. 342(8):525-533, 2000 Feb 24.

The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy
Abner, A. L.; Connolly, J. L.; Recht, A.; Bornstein, B.; Nixon, A.; Hetelekidis, S.; Silver, B.; Harris, J. R., and Schnitt, S. J.. Cancer. 88(5):1072-1077, 2000 Mar 1.

Prognostic significance of biologic markers in node-negative breas cancer patients: a prospective study. Volpi, A.; De Paola, F.; Nanni, O.;
Granato, A. M.; Bajorko, P.; Becciolini, A.; Scarpi, E.; Riccobon, A.; Balzi, M., and Amadori, D. (Reprint available from: Amadori D Pierantoni Hosp, Dept Med Oncol Via Forlanini 34 I-47100 Forli Italy). Breast Cancer Research & Treatment. 63(3): 181-192, 2000 Oct.

Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer.
Vlastos, G.; Rubio, I. T.; Mirza, N. Q.; Newman, L. A.; Aurora, R.; Alderfer, J.; Buzdar, A. U., and Singletary, S. E.. Annals of Surgical Oncology. 7(8):581-587, 2000 Sep.

A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer.
Sundquist, M.; Thorstenson, S.; Brudin, L.; Stal, O., and Nordenskjold, B. (Reprint available from: Sundquist M Cty Hosp, Dept Surg S-39185 Kalmar Sweden). Breast Cancer Research & Treatment. 63(1):11-15, 2000 Sep. In process

Approaches to breast-cancer staging.
Smith, B. L. (Reprint available from: Smith BL Massachusetts Gen Hosp Boston, MA 02114 USA). New England Journal of Medicine. 342(8):580-581, 2000 Feb 24. No abstract

The use of HER2 testing in the management of breast cancer [Review].
Ravdin, P. Seminars in Oncology. 27(5 Suppl 9):33-42, 2000 Oct. In process

Factors associated with local breast cancer recurrence after lumpectomy alone: Postmenopausal patients.
McCready, D. R.; Chapman, J. A. W.; Hanna, W. M.; Kahn, H. J.; Yap, K.; Fish, E. B., and Lickley, H. L. A.. Annals of Surgical Oncology. 7(8):562-567, 2000 Sep.

Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer.
Lohrisch, C.; Jackson, J.; Jones, A.; Mates, D., and Olivotto, I. A. Journal of Clinical Oncology. 18(15):2828 2835, 2000 Aug. No abstract

More about: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
Fox, S. B.; Gatter, K. C.; Leek, R. D.; Harris, A. L.; Chew, K. L.; Mayall, B. H., and Moore, D. H. (Reprint available from: Fox SB Christchurch Hosp, Canterbury Hlth Christchurch New Zealand).. Journal of the National Cancer Institute. 92(2):161-162, 2000 Jan 19. No abstract

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.
Chang, J.; Ormerod, M.; Powles, T. J.; Allred, D. C.; Ashley, S. E., and Dowsett, M.. Cancer. 89(11):2145-2152, 2000 Dec 1. In process

Top of Page